• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bortezomib-based chemotherapy in mantle cell lymphoma.

作者信息

Rule Simon

机构信息

University of Plymouth Medical School and Department of Haematology, Plymouth University NHS Trust, Plymouth, PL6 8DH, UK.

出版信息

Lancet Oncol. 2018 Nov;19(11):1419-1421. doi: 10.1016/S1470-2045(18)30743-5. Epub 2018 Oct 19.

DOI:10.1016/S1470-2045(18)30743-5
PMID:30348536
Abstract
摘要

相似文献

1
Bortezomib-based chemotherapy in mantle cell lymphoma.
Lancet Oncol. 2018 Nov;19(11):1419-1421. doi: 10.1016/S1470-2045(18)30743-5. Epub 2018 Oct 19.
2
Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study.在随机3期LYM-3002研究中，一线利妥昔单抗、环磷酰胺、阿霉素和泼尼松联合硼替佐米（VR-CAP）或长春新碱（R-CHOP）对一部分新诊断的符合移植医学标准的套细胞淋巴瘤患者的疗效和安全性。
Leuk Lymphoma. 2018 Apr;59(4):896-903. doi: 10.1080/10428194.2017.1365855. Epub 2018 Jan 17.
3
Phase 3 study of frontline rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in transplantation-unsuitable mantle cell lymphoma (MCL) patients.一线利妥昔单抗、环磷酰胺、阿霉素和泼尼松联合长春新碱（R-CHOP）或硼替佐米（VR-CAP）用于不适合移植的套细胞淋巴瘤（MCL）患者的3期研究。
Clin Adv Hematol Oncol. 2014 Aug;12(8 Suppl 16):9-11.
4
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.硼替佐米为基础的治疗新诊断的套细胞淋巴瘤。
N Engl J Med. 2015 Mar 5;372(10):944-53. doi: 10.1056/NEJMoa1412096.
5
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.硼替佐米联合 CHOP-利妥昔单抗方案治疗初治弥漫性大 B 细胞淋巴瘤和套细胞淋巴瘤。
J Clin Oncol. 2011 Feb 20;29(6):690-7. doi: 10.1200/JCO.2010.31.1142. Epub 2010 Dec 28.
6
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.R-CHOP方案联合硼替佐米诱导治疗继以硼替佐米维持治疗初诊套细胞淋巴瘤的II期试验：SWOG S0601
Br J Haematol. 2016 Jan;172(2):208-18. doi: 10.1111/bjh.13818. Epub 2015 Oct 22.
7
Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma.粒细胞-巨噬细胞集落刺激因子诱导的免疫启动联合环磷酰胺、多柔比星、长春新碱和泼尼松与利妥昔单抗化疗免疫治疗在未经治疗的弥漫性大 B 细胞淋巴瘤和套细胞淋巴瘤患者中的应用。
Leuk Lymphoma. 2011 Nov;52(11):2097-104. doi: 10.3109/10428194.2011.589549. Epub 2011 Jun 24.
8
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).利妥昔单抗联合环磷酰胺、阿霉素、长春新碱及泼尼松进行免疫化疗可显著提高反应率并延长至治疗失败时间，但对既往未治疗的套细胞淋巴瘤患者的长期预后无改善：德国低度淋巴瘤研究组（GLSG）一项前瞻性随机试验的结果
J Clin Oncol. 2005 Mar 20;23(9):1984-92. doi: 10.1200/JCO.2005.08.133. Epub 2005 Jan 24.
9
Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group.利妥昔单抗、阿糖胞苷和氟达拉滨联合环磷酰胺、多柔比星、长春新碱和泼尼松方案免疫化疗延长疗程并序贯利妥昔单抗维持治疗未经治疗的老年套细胞淋巴瘤患者：芬兰淋巴瘤组的前瞻性研究。
Leuk Lymphoma. 2012 Oct;53(10):1920-8. doi: 10.3109/10428194.2012.672736. Epub 2012 Apr 23.
10
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.苯达莫司汀联合利妥昔单抗与 CHOP 联合利妥昔单抗作为惰性和套细胞淋巴瘤患者一线治疗的比较：一项开放标签、多中心、随机、3 期非劣效性临床试验。
Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20.

引用本文的文献

1
Computed tomography-based conventional imaging features and texture analysis characteristics of chemotherapy drug-related acute pancreatitis.基于计算机断层扫描的化疗药物相关性急性胰腺炎的传统成像特征及纹理分析特点
Front Med (Lausanne). 2025 May 12;12:1497944. doi: 10.3389/fmed.2025.1497944. eCollection 2025.
2
Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.蛋白酶体抑制通过自噬溶酶体途径触发病毒癌蛋白降解。
PLoS Pathog. 2020 Feb 24;16(2):e1008105. doi: 10.1371/journal.ppat.1008105. eCollection 2020 Feb.